The QualityStocks Daily Friday, December 28th, 2018

Today's Top 3 StockMarketWatch

NetworkNewsWire (ASCK) +45.45%

QualityStocks (CYBF) +45.00%

PoliticsAndMyPortfolio (TXHD) +44.42%

The QualityStocks Daily Stock List

Real Goods Solar, Inc. (RGSE)

TipRanks, Stockflare, ClayTrader, Dividend Investor, Central Charts, Simply Wall St, YCharts, Infront Analytics, InvestorsHub, Stockhouse, Penny Stock Tweets, Wallet Investor, Morningstar, MarketWatch, Investor Place, Penny Stock Hub, Barchart, GuruFocus, Real Investment Advice, 4-Traders, last10k, and Capital Cube reported on Real Goods Solar, Inc. (RGSE), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Real Goods Solar, Inc.’s RGS Energy (America’s Original Solar Company®) operates in the U.S. as a residential and small business commercial solar energy engineering, procurement, and construction company. The Company has installed over 25,000 solar energy systems for homes, businesses, schools, government facilities, and utilities across the nation. This has totaled greater than 260 megawatts of clean energy. Real Goods Solar (RGS Energy) is based in Denver, Colorado. RGS Energy is the Company’s registered trade name.

In addition, the Company is also the exclusive manufacturer of POWERHOUSE™ - an inventive in-roof solar shingle using technology developed by The Dow Chemical Company. RGS Energy entered into an exclusive domestic and worldwide license agreement with The Dow Chemical Company for the POWERHOUSE™ solar shingles system. RGS will lead all commercial activities for the product.

RGS Energy’s Solar Division consists of its Residential and Sunetric business segments. The Corporate segment includes administrative costs associated with administrative services, legal settlements, legal, information systems, and accounting and finance. POWERHOUSE™ is the Company’s business segment.

RGS Energy has its Solar 365™. This is a mobile software and online dashboard suite. With Solar 365™, users can access information and documents regarding their planned solar installation wherever and whenever it is convenient. After installation, customers can easily access and view their cost savings and production stats in kilowatts and dollars earned if net metering.

RGS Energy has its RGS POWERHOUSE™ 3.0 Solar Shingle. This is an innovative and visually appealing solar shingle system utilizing technology developed by The Dow Chemical Company.

Yesterday, RGS Energy announced it accepted its first customer purchase order for POWERHOUSE™. Mr. Dennis Lacey, Chief Executive Officer of RGS Energy, said, “We have now successfully manufactured our product as planned and accepted our first customer purchase order. We remain on track for revenue to increase substantially in the first quarter of the new year. We have already arranged with our supply chain partners for over 5 megawatts of POWERHOUSE™ to be manufactured and ready for distribution during the first quarter. We plan to increase the number of POWERHOUSE™ shingles manufactured each quarter throughout 2019.”

Real Goods Solar, Inc. (RGSE), closed Friday's trading session at $0.5356, up 2.21%, on 3,237,226 volume with 5,077 trades. The average volume for the last 3 months is 7,311,451 and the stock's 52-week low/high is $0.30/$1.79.


Glance Technologies, Inc. (GLNNF)

Connecting Investor, Stockhouse, GuruFocus, Evergreen Caller, MarketWatch, InvestorsHub, Wallet Investor, TradingView, InvestorsHub, Emerging Growth, Insider Financial, and Stock Invest reported earlier on Glance Technologies, Inc. (GLNNF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Glance Technologies, Inc. owns and operates Glance Pay - a streamlined payment system. Glance Pay transforms how smartphone users choose where to dine, order food and drink, settle bills, access digital receipts, earn premier rewards, and interact with merchants. With the Glance Pay mobile payment app, there is no set up or cancellation fees and no system integration or connections required. Glance Technologies has its corporate office in Vancouver, British Columbia.

The Glance Pay mobile payment system consists of proprietary technology. This technology includes user apps available for free downloads in IOS (Apple) and Android formats, a merchant manager apps, a large-scale technology hosting environment with sophisticated anti-fraud technology, and very quick payment processing.

Glance Technologies offers targeted in-app marketing, social media marketing, customer feedback, in-merchant messaging, and custom rewards programs. The Glance Pay mobile payment app works for full service restaurants, quick serve restaurants (QSRs), retail, and more. In addition, it features easy activation and training, easy automatic accounting and reconciliation, and fast payment deposits.

Moreover, Glance intends to apply components of its anti-fraud technology to cryptocurrencies. This is to reduce the risk associated with converting traditional currencies to and from cryptocurrencies. The Company is going after opportunities to license its previoulsy acquired BlockImpact cryptocurrency and blockchain platform as a white label solution. Its belief is that there is high demand in the marketplace for applications of this technology platform.

Glance Technologies and BIG Blockchain Intelligence Group, Inc. jointly announced this past July that they entered into a Strategic Alliance Agreement. With the Agreement, BIG and Glance will work together to create a mutual referral and strategic marketing relationship; further explore ways to work together; and collaboratively market and promote the businesses of BIG and Glance. BIG is a leading developer of Blockchain technology search, data analytics solutions.

Glance Technologies has launched its new Pay With Bitcoin feature.  Pay With Bitcoin allows Glance Pay users to pair their cryptocurrency wallet with their Glance Pay account, and subsequently purchase Glance Dollars with Bitcoin. Glance Dollars represent a credit that can be spent promptly at participating merchants within the Glance Pay ecosystem.

Last week, Glance Technologies announced that it filed a provisional patent application with the United States Patent and Trademark Office (USPTO) directed at methods, systems and techniques for cryptographic token transfers. The patent application is for a foundational technology to lessen costs and improve speed and efficiency of cryptocurrency transactions, even where the value of the transaction may be relatively small, and also to facilitate converting between cryptocurrencies whose transactions are recorded on different blockchains. Additionally, it facilitates storing information of different sensitivity levels on differently permissioned blockchains that can be useful when privacy is vital.

Glance Technologies, Inc. (GLNNF), closed Friday's trading session at $0.09, down 3.23%, on 494,613 volume with 119 trades. The average volume for the last 3 months is 378,075 and the stock's 52-week low/high is $0.0855/$1.95.


Lixte Biotechnology Holdings, Inc. (LIXT)

Spotlight Growth, Real Pennies, Proactive Investors, Penny Stock Hub, YCharts, Stockhouse, 4-Traders, MarketWatch, InvestorsHub, and Simply Wall St reported earlier on Lixte Biotechnology Holdings, Inc. (LIXT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. is a drug discovery company listed on the OTCQB. The Company utilizes biomarker technology to identify enzyme targets associated with serious common diseases and subsequently designs novel compounds to attack those targets. Lixte’s product pipeline covers two major categories of compounds at varied stages of pre-clinical and clinical development that the Company believes have wide-ranging therapeutic potential for cancer and other debilitating and life-threatening diseases. A clinical-stage company, Lixte Biotechnology has its corporate office in East Setauket, New York.

Lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. Its cancer drug development strategy has led to the discovery of novel compounds. The deacetylase inhibitors are in pre-clinical development for the prevention and treatment of neurodegenerative diseases, traumatic brain injury, and topically for fungal dermatitis. The phosphatase inhibitors are in pre-clinical development for reducing the extent of tissue damage following stroke, heart attack, and septic shock.

At present, the Company’s drug portfolio includes inhibitors of serine/threonine protein phosphatases that are crucial to cell division. Lixte’s portfolio also includes DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.

Lixte’s unique phosphatase inhibitor is LB-100, its lead compound. LB-100 is in a Phase I clinical trial at two NCI designated Comprehensive Cancer Centers and three U.S. Oncology Research locations. The Company granted an exclusive license of its LB-100 for the treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). Currently, LB-100 is not approved for treatment of HCC.

Lixte Biotechnology announced this past October that it submitted an IND to the Food and Drug Administration (FDA) to conduct a Phase 1b/2 trial of the safety and therapeutic benefit of lead clinical compound, LB-100, in patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) who have failed or are intolerant of standard treatment. The study will take place at Moffitt Cancer Center, Tampa, Florida.

In November, Lixte Biotechnology announced that the FDA approved its IND to conduct a Phase 1b/2 trial of the safety and therapeutic benefit of the Company’s lead clinical compound, LB-100, in patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) who have failed or are intolerant of standard treatment.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Friday's trading session at $0.80, down 14.89%, on 16,075 volume with 5 trades. The average volume for the last 3 months is 6,619 and the stock's 52-week low/high is $0.125/$1.84.


MRI Interventions, Inc. (MRIC)

NetworkNewsWire, Investing Note, FeedBlitz, Insider Financial, Earnings Cast, Stockhouse, Dividend Investor, Wallmine, Capital Cube, Market Exclusive, Wall Street Resources, InvestorsHub, Real Pennies, Stockhouse, and 4-Traders reported previously on MRI Interventions, Inc. (MRIC), today we highlight the Company, here at the QualityStocks Daily Newsletter.

MRI Interventions, Inc. is a commercial stage medical device company based in Irvine, California. It develops and commercializes distinct platforms for performing minimally invasive surgical procedures in the brain under direct, intra-procedural Magnetic Resonance Imaging, or MRI, guidance. Using a hospital's existing MRI suite, the design of its Food and Drug Administration (FDA)-cleared and CE-marked ClearPoint® system is to enable a range of minimally invasive procedures in the brain.

The Company’s focus is Magnetic Resonance Imaging (MRI)-Guided Neurosurgical procedures. The ClearPoint® system enables real-time MRI-guided navigation for a broad variety of minimally-invasive neurosurgery procedures. The ClearPoint® system is the only navigation platform designed to allow real-time visualization during minimally-invasive neurosurgical procedures. The platform is especially well-matched for facilitating drug delivery directly to brain tumors.

The ClearPoint® system provides MRI-based stereotactic guidance for the placement and operation of instruments or devices during the planning and operation of neurological procedures performed within the MRI suite. ClearPoint® procedures can be used with 1.5T and 3T scanners.

MRI Interventions has a co-development and co-distribution agreement with Brainlab regarding the ClearPoint® system. Brainlab is a leader in software-driven medical technology. In addition, MRI Interventions is developing the ClearTrace® system in partnership with Siemens Healthcare. This is to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.

Earlier this month, MRI Interventions announced participation in the RESTORE-1 gene therapy trial for Parkinson’s disease sponsored by Voyager Therapeutics. With this agreement with Voyager, MRI Interventions provided the navigation system and drug infusion cannulae, and also clinical support during the procedure to assist the Voyager team in executing the clinical protocol.

The Phase 2 RESTORE-1 trial is looking to enroll patients who have been diagnosed with Parkinson’s disease for at least four years, are not responding adequately to oral medications, and have a minimum of three hours of OFF time during the day as measured by a validated self-reported patient diary. Patients who meet the eligibility criteria will be randomized (1:1) to one-time administration of VY-AADC (for a total dose of up to 2.5×1012 vector genomes) or placebo surgery.

MRI Interventions, Inc. (MRIC), closed Friday's trading session at $1.6875, up 4.88%, on 14,059 volume with 20 trades. The average volume for the last 3 months is 6,411 and the stock's 52-week low/high is $1.33/$3.65.


New Jersey Mining Company (NJMC)

Equity Clock, 4-Traders, The Street, InvestorsHub, Zacks, SmallCapVoice, London Irvine Report, Plunkett Research, Marketbeat, and Market Screener reported earlier on New Jersey Mining Company (NJMC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New Jersey Mining Company has constructed, and is the majority-owner and operator, of a fully-permitted, upgraded, 360-ton per day flotation mill and cyanide leach plant. It is also 100-percent owner of the Golden Chest Mine project. This is an historic lode gold producer that has been expanded, modernized, and operated by a first-class lessee. OTCQB-listed, New Jersey Mining is headquartered in Coeur d'Alene, Idaho. Its Mill office is in Kellogg, Idaho.

New Jersey Mining provides custom milling services for small-scale mining operations. The Company can offer, for larger companies, a variety of mining and exploration services, including custom milling. It is pursuing near-term production of its own, with a longer-term vision toward district-scale deposit potential.

New Jersey Mining is ramping up the flotation mill to handle incoming ore shipments from the nearby Golden Chest Mine. The Golden Chest Mine is now producing gold from open pit and underground operations. The flotation mill recycles process water. It uses a paste tailings disposal process patented by Company founder Mr. Fred Brackebusch to reduce impact on the environment. The New Jersey Mill can perform test and toll milling on material from mines and prospects within a wide radius of active mining camps in Montana, Idaho, and Washington.

In March 2018, New Jersey Mining announced that it added to its land holdings in North Idaho’s Murray Gold Belt (MGB) with the lease of the Four Square Property. The Four Square Property consists of 334 acres of mining claims, including 46 acres of patented mining claims, located near the town of Murray, three miles west of the  Golden Chest Mine. Additionally, New Jersey Mining acquired, via staking, 348 additional acres of unpatented mining claims south of the leased area, next to the patented claims.

At the Golden Chest Mine, New Jersey Mining plans to drill through the winter and into the foreseeable future. The Company’s drill programs are centered on near-term and long-term evaluation, planning and development at the Golden Chest Mine. The addition of a second diamond drill is presently undergoing consideration.

New Jersey Mining Company (NJMC), closed Friday's trading session at $0.1417, down 16.65%, on 10,339 volume with 5 trades. The average volume for the last 3 months is 42,782 and the stock's 52-week low/high is $0.127/$0.247.


Mentor Capital, Inc. (MNTR)

Wealth Insider Alert, Market Intelligence Center Alert, Investors Underground, Cancer Roll Up Strategy, Stock Profile, Promotion Stock Secrets, Laissez Faire Today, BUYINS.NET, Stocks That Move, Stockgoodies, StreetAuthority Daily, and Five Star Stock Picks reported earlier on Mentor Capital, Inc. (MNTR), and today we report on Company, here at the QualityStocks Daily Newsletter.

Mentor Capital, Inc. provides mezzanine financing to leaders in the cannabis arena. It looks to come alongside and assist larger private medical marijuana and cannabis companies and their founders in meeting their liquidity, and financial goals, to add protection for investors, and to help incubate private cannabis companies. Listed on the OTCQX, Mentor Capital has its head office in San Diego, California.

Mentor participates in the legal recreational marijuana market. However, its favored focus is medical. It looks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing ocular pressures from glaucoma, in addition to reducing chronic pain. Mentor takes a major position in the diverse members of its portfolio of participating companies. Nonetheless, it leaves operating control in the hands of the cannabis company founders.

Mentor Capital’s preferred involvement is with larger and private pre-IPO (Initial Public Offering) medical marijuana companies, which it can help operationally prepare for the public market and finance, sometimes working with institutional partners looking for public liquidity. The Company transferred to the cannabis space from front-line cancer investments.

Mentor Capital announced in February 2018 that it extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Mentor stated it would be pleased to make a series of cannabis centered investments with cannabis veteran and Pueblo Founder, Pat Leonard. Mentor Capital has set up Mentor Partner II, LLC as a channel for this purpose.

For the quarter ended September 30, 2018, Mentor Capital had revenues of $1,031,622 and gross profit of $300,501 with a resulting net income attributable to the Company of $77,224 or 0.3 cents per share. This represents an improvement over the year ago quarter ended September 30, 2017 revenues of $815,102 and gross profit of $289,211, with a resulting net loss attributable to Mentor of ($285,796) or (1.3 cents) per share.

For the nine months ended September 30, 2018, Mentor had revenues of $3,279,080 and gross profit of $1,024,771 with a resulting net loss attributable to Mentor of ($149,087) or (0.6 cents) per share. This represents an improvement over the nine months ended September 30, 2017 revenues of $2,317,794 and gross profit of $821,771, with a net loss attributable to the Company of ($922,653) or (4.2 cents) per share.

Mentor Capital, Inc. (MNTR), closed Friday's trading session at $0.31, down 5.33%, on 85,137 volume with 84 trades. The average volume for the last 3 months is 63,632 and the stock's 52-week low/high is $0.31/$2.65.


Aerpio Pharmaceuticals, Inc. (ARPO)

Market Chameleon, Stocktwits, 4-Traders, Barchart, Zacks, Business Wire, OTC Markets, Morningstar, HotStockCafe, HighRisingStocks, Street Insider, OTC Stock Picks, MarketWatch, and Insider Tracking reported earlier on Aerpio Pharmaceuticals, Inc. (ARPO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Aerpio Pharmaceuticals, Inc. concentrates on first-in-class treatments for ocular diseases. Its lead compound is AKB‐9778. This is a small molecule activator of the Tie2 pathway. It is in clinical development for the treatment of non-proliferative diabetic retinopathy. A biopharmaceutical Company, Aerpio Pharmaceuticals is headquartered in Cincinnati, Ohio.

At present, AKB-9778 is in a Phase 2b study (TIME-2b) for the treatment of non-proliferative diabetic retinopathy (NPDR). Diabetic Retinopathy (DR) is a complication of diabetes caused by damage to blood vessels in the retina. AKB-9778 is undergoing development as a subcutaneous injection.

Aerpio Pharmaceuticals’ second program in development builds on its innovative approach to targeting the Tie2 pathway. ARP-1536 is a humanized monoclonal antibody. It works by binding the extracellular domain of VE-PTP, inhibiting its ability to interact with the Tie2 receptor. This prevents the inactivation of Tie2. Additionally, it promotes vascular stability.

ARP-1536 is in pre-clinical development. The Company’s plan is to develop ARP-1536 in combination with anti-VEGF therapy for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Moreover, AKB-4924 is in Phase 1 clinical development. Aerpio’s plan is to develop it as a once-daily, oral treatment for inflammatory bowel disease (IBD). AKB-4924 is a unique small molecule inhibitor of prolyl-hydroxylase domain enzymes (PHDs).

Last month, Aerpio Pharmaceuticals reported financial results for Q3 ended September 30, 2018 and provided a business update. Mr. Stephen Hoffman, M.D., Ph.D., Chief Executive Officer of the Company, said, “Our TIME-2b clinical trial, evaluating the effect of AKB-9778, our first-in-class systemically administered Tie2 activator in patients with non-proliferative diabetic retinopathy (NPDR), is on track and we look forward to reporting top-line results in early Q2 2019.”

Regarding Aerpio’s financials, net income attributable to common shareholders for the three months ended September 30, 2018 was $11.5 million, or $0.28 earnings per share, versus a net loss attributable to common shareholders of $4.6 million, or $0.17 net loss per share, for the same period in 2017. Net loss attributable to common shareholders for the nine months ended September 30, 2018 was $1.9 million, or $0.06 net loss per share, versus a net loss attributable to common shareholders of $16.1 million, or $0.81 net loss per share, for the nine months ended September 30, 2017.

Aerpio Pharmaceuticals, Inc. (ARPO), closed Friday's trading session at $1.71, up 6.88%, on 183,764 volume with 616 trades. The average volume for the last 3 months is 69,029 and the stock's 52-week low/high is $1.56/$5.25.


AmeriCann, Inc. (ACAN)

NetworkNewsWire, last10k, OTC Markets Group, Real Pennies, TopPennyStockMovers, Promotion Stock Secrets, Cannabis Financial Network News, SmallCapVoice, TheMicrocapNews, and Dividend Investor reported previously on AmeriCann, Inc. (ACAN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AmeriCann, Inc. is developing sustainable, state-of-the-art, medical cannabis cultivation properties. It is a national leader of sustainable cultivation and processing infrastructure for the medical marijuana industry. AmeriCann designs, builds, and owns efficient cultivation and processing facilities to produce medical cannabis. The Company is developing projects across the nation in regulated markets through the “Preferred Partner Program”. An Agricultural Technology Company, AmeriCann is headquartered in Denver, Colorado. The Company lists on the OTC Markets Group’s OTCQB.

The Company identifies, acquires, and develops real estate particularly suited for cannabis operations. It finances real estate development. Furthermore, AmeriCann provides necessary venture capital to developing cannabis enterprises.  

AmeriCann is developing a 53-acre property in Massachusetts as the Massachusetts Medical Cannabis Center (the MMCC). The MMCC has approval for close to 1 million square feet. The expectation is that it will be one of the most technologically advanced cultivation facilities in the nation. AmeriCann has agreements with Coastal Compassion, Inc. (CCI), its Preferred Partner in Massachusetts, to lease 100 percent of the first phase of MMCC.

AmeriCann has its Preferred Partner in Massachusetts, Bask, Inc. (BASK of BASK Premium Cannabis). AmeriCann established an alliance with BASK in 2016 as a Preferred Partner in Massachusetts. BASK is scheduled to be the first business to operate in AmeriCann's Massachusetts Medical Cannabis Center (MMCC).

This month, AmeriCann provided an update on construction and Adult-Use sales in Massachusetts. The Company has started construction on the MMCC on the property located in Southeastern Massachusetts.

Construction on the first building at MMCC, a 30,000 square foot greenhouse cultivation and processing facility, which will be 100 percent leased by Bask, Inc., includes vertical steel installation and concrete foundations. This building is scheduled for completion in the summer of 2019. AmeriCann recently announced plans to construct and operate an advanced large-scale processing and product manufacturing facility in the second building at MMCC.

AmeriCann, Inc. (ACAN), closed Friday's trading session at $2.11, even for the day, on 34,950 volume with 82 trades. The average volume for the last 3 months is 69,140 and the stock's 52-week low/high is $1.70/$5.35.


Breaking Data Corp. (BKDCF)

Savvy Trader Resource, Penny Stock Tweets, Stockhouse, FinanceSpotlight, Capital Cube, Marketwired, The Street, MarketWatch, Barchart, Small Cap Exclusive, OTC Markets, InvestorsHub, Morningstar, Capital Equity Review, Seeking Alpha, and 4-Traders reported on Breaking Data Corp. (BKDCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Breaking Data Corp. is a technology provider of a range of Artificial Intelligence (AI) services. These include semantic search, machine learning, as well as natural language processing (NLP). The Company previously went by the name Sprylogics International Corp. It changed its name to Breaking Data Corp. in September of 2015. OTCQX-listed, Breaking Data is headquartered in Toronto, Ontario.

The Company’s technology platform has many practical applications in a host of business and consumer verticals that are immersed in massive media and data rich settings. Its showcase app is BreakingSports.

BreakingSports uses semantic machine learning and NLP to track social media in a totally automated, real-time way for major sports information and events. BreakingSports distributes summarized information through real-time push notifications to consumers.

Breaking Date has acquired GIVEMESPORT. It is now the Company’s wholly-owned subsidiary. GIVEMESPORT is a foremost next generation sports media business. Breaking Data launched an innovative AI-powered App focused on personalization, speed and user experience. The GIVEMESPORT Android App is available on the Google Play Store. Powered by Breaking Data’s AI, Natural Language Processing and Machine Learning technology, the GIVEMESPORT App provides access to sports news, scores, videos, stats, and live match updates and news from trusted sources in sports.

Breaking Data announced this past September that it sold its Toronto-based technology team to Highground Technologies Corporation. With the deal, Breaking Data will retain an agreement that will allow it to use the AI previously built and to continue to develop machine-learning based systems for GIVEMESPORT and GIVEMEBET.

GIVEMEBET is a new online sports betting brand. It will complement GIVEMESPORT’s leading position in digital sports publishing. Breaking Data will retain a 10 per cent stake in VRFY, which is a subsidiary of Highground Technologies.

Breaking Data plans to acquire Oryx Gaming and leverage the 26m Facebook fans to move into gaming. Upon the completion of the acquisition of Oryx Gaming, the Company will be renamed Bragg Gaming Group.

Breaking Data Corp. (BKDCF), closed Friday's trading session at $0.614, even for the day. The average volume for the last 3 months is 5,798 and the stock's 52-week low/high is $0.35/$2.43.


Intrusion, Inc. (INTZ)

Zacks, Investing Online, Marketbeat, 4-Traders, Investor Place, Wallstreet Online, Morningstar, Market Screener, InvestorsHub, Wallet Investor, Barchart, The Street, Stockopedia, Capital Cube, OTC Markets, and MarketWatch reported earlier on Intrusion, Inc. (INTZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Intrusion, Inc. is a global provider of entity identification, high speed data mining, cybercrime, and advanced persistent threat detection products. Its product families include TraceCop™ for identity discovery and disclosure, and Savant™ for network data mining and advanced persistent threat detection. The Company also has its Secure Taps™. It offers a collection of secure network taps. These enable easy, fast, and strong deployment of any of Intrusion’s network security appliances. Intrusion is based in Richardson, Texas and the Company lists on the OTCQB.

Intrusion’s products help protect critical information assets. These products do so through quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private, and regulated information for government and enterprise networks.

The Company’s TraceCop is a set of Internet monitoring and tracking products. They provide exceptional capabilities for the identification of malicious and illegal activities based on historical and current Internet usage data. At the heart of TraceCop is a first-rate data collection process.

This process continuously collects, processes and stores extensive amounts of historical Internet usage and traffic data into the TraceCop Databases. TraceCop helps analysts and investigators considerably lessen the time and complexity for discovering identities, ownership, and contact information for computer devices on the Internet.

The Company’s Savant is a transparent network data capture and analysis solution. Savant brings science into corporate decision making. It provides real-time access and insight into an enterprise’s own indisputable and quantifiable network data for more effective, unbiased decision making.

Savant is a purpose-built appliance. It performs a unique, real-time, transparent data capture and analysis of all content across a company’s network. This includes the “who, what, when and where” of the data from any application.

Last month, Intrusion announced financial results for the three and nine months ended September 30, 2018. The Company’s net income was $0.62 million in Q3 2018 versus a net income of $0.57 million in Q3 2017. Its revenue for Q3 2018 was $2.7 million versus $1.7 million in Q3 2017. Gross profit was $1.7 million or 64 percent of revenue in Q3 2018 versus $0.9 million or 56 percent of revenue in Q3 2017.

Intrusion, Inc. (INTZ), closed Friday's trading session at $3.80, even for the day, on 41,443 volume with 80 trades. The average volume for the last 3 months is 14,004 and the stock's 52-week low/high is $0.81/$3.83.


Probe Metals, Inc. (PROBF)

PennyStockHub, Stockhouse, MarketWatch, 4-Traders, Investopedia, Investing, Macroaxis, Morningstar, Barron’s, The Street, InvestorsHub, OTC Markets, Junior Mining Network, Agoracom, Northern Miner, Marketwired, and Barchart reported previously on Probe Metals, Inc. (PROBF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Probe Metals, Inc. engages in the acquisition, exploration, and development of gold properties. The Company controls a strategic land package of more than 1,000-square-kilometers of exploration ground within some of the most prolific gold belts in Quebec - Val d’Or, est Timmins, Casa-Berardi, and Detour Quebec. OTCQB-listed, Probe Metals is headquartered in Toronto, Ontario.

The Company’s main asset is the 100 percent owned Val-d’Or East Gold Project in the Province of Quebec. The Val-d'Or East Project comprises the Pascalis, Lapaska, and Megiscane-Tavernier Properties. The Val d'Or East Project consists of 293 claims totaling 11,904 hectares of land, controlled by Probe Metals, situated about 25 kilometers east of the city of Val-d'Or in Quebec. Probe’s landholdings in Val-d’Or are currently 327 square kilometers. This makes it one of the largest consolidated land packages in the Val-d'Or Mining Camp.

Probe also has its Black Creek Chromite Project in the Province of Ontario. The Black Creek Chromite deposit is in the James Bay Lowlands in an area known as "The Ring of Fire". The Company also has its Detour Quebec Project. This project includes 100 percent owned properties and the 75 percent Probe-SOQUEM JV (Joint Venture) properties.

Probe Metals completed the asset purchase of the Aurbel East property from QMX Gold Corporation in 2017. This Property is adjacent to its Val-d'Or East Project near Val-d'Or, Quebec. Other Projects include the Casa Cameron Project in Quebec. This Project includes properties located north of La Sarre, Amos and Lebel-sur-Quevillon, in the northwest region of the Province. Other Projects include the Dubuisson property in Dubuisson Township, Quebec; and the Timmins West in Ontario (the Meunier-144 JV property is in the western part of the prolific Timmins gold camp).

In late November, Probe Metals provided new results from the 2018 drill program on the Val-d’Or East Courvan property area near Val-d’Or, Quebec. Results from 25 drill holes, totaling 8,285 meters, were received. They showed significant new discoveries north and south of the Former Bussiere Mine. The discoveries have opened up a new area for exploration within a short distance from Probe’s current resources. They will be a priority focus of the winter drilling program.

Last week, Probe Metals provided new results from its 2018 drill program on the Val-d’Or East Pascalis property near Val-d’Or, Quebec. Results from 39 drill holes, totaling 15,438 meters, were received. They show continued expansion and strong continuity of the gold resource within the Pascalis Gold Trend. The 2018 drilling program has been completed with greater than 108,000 meters drilled on the Val-d’Or East property in 334 holes. Results for the remaining holes drilled in 2018 will be released in early 2019.

Probe Metals, Inc. (PROBF), closed Friday's trading session at $0.98, up 11.36%, on 61,627 volume with 16 trades. The average volume for the last 3 months is 67,617 and the stock's 52-week low/high is $0.6835/$1.23.


Millennial Lithium Corp. (MLNLF)

Junior Mining Network, Morningstar, Small Cap Leader, Zacks, Stockpulse, The Street, Penny Stock Tweets, Streetwise Reports, TradingView, OTC Markets, TipRanks, Insider Financial, Stockwatch, Investing News, Barchart, Stockhouse, 4-Traders, Metals News, and Investors Hub reported earlier on Millennial Lithium Corp. (MLNLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Millennial Lithium Corp. is an emerging exploration and development company based in Vancouver, British Columbia. It is focusing on world class lithium assets in Argentina. The Company’s commitment is to advancing the Pastos Grande Lithium project and the Cauchari East lithium project. Millennial Lithium’s shares trade on the OTC Markets Group’s OTCQX.

Millennial Lithium controls greater than 35,000 hectares of claims in the core of the Lithium Triangle. The Lithium Triangle is home to the world’s most prolific lithium deposits. The Pastos Grandes Project is the Company’s flagship project. This Project is in Salta Province, Argentina. Currently, the Pastos Grandes Project covers 6,361 hectares. This makes Millennial Lithium the most active company in this expansive salar.

Millennial Lithium has an option to acquire 100 percent of the Pastos Grandes Lithium Project. The timeline to production is three years and 9 wells have been drilled and $9 Million spent in development.

Millennial Lithium entered into the final agreement with the Salta Provincial Energy and Mining Company (REMSA) in December 2017 for the acquisition of 2,492 hectares of claims strategically located in the Pastos Grandes Salar and neighboring the Company’s current land holdings there. Completion of this acquisition brings Millennial Lithium’s holdings at Pastos Grandes to 8,664 hectares.

The Company’s Cauchari East Project is one of the world’s most prospective, shovel-ready lithium brine development projects. It is at the core of the Lithium Triangle. Millennial Lithium is working towards the completion of a 43-101 resource calculation.

Last month, Millennial Lithium reported positive drilling and analytical results from the latest exploration well at its Pastos Grandes Project in Salta, Argentina. Exploration well PGMW18-19 intersected, and bottomed, in a strong lithium-bearing brine zone that yielded 566 mg/l Li, 5,733 mg/l K, and 3,385 mg/l Mg from 366m to the bottom of the hole at 602m for an intersection thickness of 236m.

Millennial Lithium President and Chief Executive Officer, Farhad Abasov, said, "We are very encouraged to see that additional drilling on the eastern portion of the REMSA license at Pastos Grandes salar has intersected robust lithium values and very suitable chemistry for development via solar evaporation and conventional processing.”

Millennial Lithium Corp. (MLNLF), closed Friday's trading session at $0.7785, down 1.46%, on 20,163 volume with 17 trades. The average volume for the last 3 months is 15,374 and the stock's 52-week low/high is $0.705/$3.87.


Hunter Oil Corp. (HOILF)

OTC Markets, Wallmine, Penny Stock Hub, Stockhouse, Penny Stock Tweets, Stockwatch, Investor Network, InvestorsHub, TradingView, Canadian Insider, and Capital Cube reported earlier on Hunter Oil Corp. (HOILF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Hunter Oil Corp., by way of its subsidiaries, acquires, develops, operates, and exploits crude oil and natural gas properties in the United States. The Company formerly went by the name Enhanced Oil Resources, Inc. It changed its corporate name to Hunter Oil Corp. in August 2016. OTCQX-listed, Hunter Oil is based in Vancouver, British Columbia.

The Company owns and operates two large, historic oil fields in the Permian Basin of Eastern New Mexico. These are the Milnesand and Chaveroo fields. Historical production of these two fields is about 40 million barrels. The Milnesand and Chaveroo fields were initially developed in the 1950’s and 1960’s with vertical well production technology. This left significant recoverable reserves behind.

Hunter Oil has a 100 percent Working Interest (WI) in Milnesand and Chaveroo. In the Permian Basin of New Mexico the Company holds more than 23,000 gross acres. The Company has been preparing its Chaveroo and Milnesand Oil fields for an infield horizontal redevelopment of the San Andres formation, providing Hunter with drill-ready assets. Its preparations include obtaining an agreed compliance order (ACO) with the New Mexico Conservation Division.

This past October, Hunter Oil announced it completed the earlier announced return of capital distribution of USD $1.25 (CAD $1.625) per common share. The distribution represents substantially all of the proceeds received by Hunter Oil from the sale of the Company’s assets announced August 31, 2018, less outstanding liabilities and a reserve for working capital. Hunter Oil now plans to seek to locate, evaluate, and where advisable, negotiate to acquire interests in more oil and gas properties.

In late November, Hunter Oil announced the appointment of Mr. Bryant Pike as the Company's Chief Financial Officer (CFO), effective immediately. Mr. Pike is a CPA (Certified Public Accountant). He has more than 15 years of financial experience. Mr. Pike previously served as CFO and Senior Vice President of Corporate Development for Wow Unlimited Media, Inc. (previously Rainmaker Entertainment) from 2008 through 2017.

Hunter Oil Corp. (HOILF), closed Friday's trading session at $0.1426, up 8.44%, on 2,500 volume with 1 trade. The average volume for the last 3 months is 729 and the stock's 52-week low/high is $0.0182/$2.01.


Covalon Technologies Ltd. (CVALF)

Stockhouse, Barchart, OTC Markets, TradingView, InvestorsHangout, Proactive Investor, Penny Stock Picks, Penny Stock Tweets, Wallet Investor, 4-Traders, InvestorsHub, CapitalCube, and Stockwatch reported previously on Covalon Technologies Ltd. (CVALF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Covalon Technologies Ltd. is an advanced medical technologies company listed on the OTC Markets Group’s OTCQX. Covalon researches, develops and commercializes new healthcare technologies. Its patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers, as well as individual consumers. Covalon Technologies is based in Mississauga, Ontario.

The Company’s technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. Its Advanced Wound Care line has been expressly designed for the successful treatment of a broad array of wounds.

Regarding Infection Prevention, Covalon Technologies has its highly lubricious and first-rate antimicrobial protection SilverCoat™ Foley catheter. In addition, it has its dual antimicrobial silicone adhesive platform across the MediClear™ PreOp, SurgiClear™ and IV Clear™ brands.

Covalon’s Perioperative Care brands, MediClear™ and SurgiClear™ offer a range of care throughout a patient’s surgical journey. The Company has its Technology platforms. These are its Biomatrix Platform, its Antimicrobial Silicone Platform, and its Medical Coating Platform.

Covalon Technologies announced recently that it closed the acquisition of AquaGuard. This is the Seattle, Washington-based division of medical technologies company Cenorin, LLC. AquaGuard's specialized products provide patients with important moisture protection for wound, surgical, and vascular access sites throughout the body while showering. Covalon acquired all of the assets and staff dedicated to the AquaGuard business from Cenorin, LLC. Covalon Technologies’ efforts to enter the European and Latin American markets are expected to begin to contribute to the Company’s revenue in fiscal 2019.

Last week, Covalon Technologies announces its Fiscal 2018 year-end results. Fiscal 2018 was profitable with $0.07 EPS on $26.7 million of revenue. The expectation is that Fiscal 2019 contracted Middle East revenue will be about $30 million, more than double the contracted revenue of fiscal 2018. The Fiscal 2019 acquisition of AquaGuard more than doubles United States revenue to roughly $25 million before internal growth.

Covalon Technologies Ltd. (CVALF), closed Friday's trading session at $3.10, up 3.33%, on 5,028 volume with 10 trades. The average volume for the last 3 months is 3,145 and the stock's 52-week low/high is $2.55/$7.12.


The QualityStocks Company Corner

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), will exhibit at the Cantech Investment Conference 2019, taking place on January 29-30 in Toronto, and it will participate in a specialized event where it will meet technology investors. Cantech ( will feature an analysis of cannabis edibles, as well as a presentation on cannabis medical applications and R&D (

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.01, up 16.09%, on 127,376 volume with 102 trades. The average volume for the last 3 months is 184,343 and the stock's 52-week low/high is $0.75/$2.54.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a Cannabis-focused research and development company, believes 2019 will be an excellent year for company growth as it works to reach an output of at least 170,000 kilograms per year. To view the full article, visit:

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $1.85, up 13.50%, on 944,859 volume with 1,258 trades. The average volume for the last 3 months is 1,049,812 and the stock's 52-week low/high is $1.61/$7.89.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX), a premier provider of financial information to Chinese-speaking investors in the United States and China, recently announced the appointment of Alex Hamilton as chief financial officer of CBD Biotechnology, LTD, the company’s wholly owned subsidiary. Hamilton will be supervising a myriad of corporate responsibilities within the company and, ultimately, aims to execute CBD Biotech’s goal of providing cannabidiol (CBD)-related products to China’s mainland population, which Hamilton ( calls the “largest market ever.”

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.52, up 4.00%, on 108,511 volume with 67 trades. The average volume for the last 3 months is 430,661 and the stock's 52-week low/high is $0.365/$1.25.

Recent News


BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

For nearly 20 years, researchers have been working on ways to help the immune system better target cancer. New developments in the field are making that possible, which is why clinicians believe that immunotherapy could be the future of cancer treatment ( Companies like BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a Berkeley-based clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer, are making solid progress in the field of immunotherapy aimed at targeting specific types of cancer. Bria-IMT™, the company’s lead product candidate, has delivered promising results in three clinical studies to date.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.052, up 5.05%, on 75,000 volume with 2 trades. The average volume for the last 3 months is 19,274 and the stock's 52-week low/high is $0.049/$0.135.

Recent News


Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions (OTC: DVLP), an emerging leader in the cannabis, hemp, and cannabidiol (“CBD”) marketplace, is set to benefit from Congress recently passing the 2018 Farm Bill, loosening restrictions on the cultivation and sale of hemp. To view the full article, visit:

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website ( and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially. has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0157, up 11.35%, on 1,400 volume with 1 trade. The average volume for the last 3 months is 567,928 and the stock's 52-week low/high is $0.012/$0.14.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

After years of prohibition, industrial hemp has now been federally legal for a little more than a week. President Trump signed off on the 2018 Farm Bill December 20th, which means hemp is no longer a schedule one substance. This is a huge win and opportunity for SinglePoint, Inc. (OTC:SING). The company’s subsidiary is an ecommerce-based business that sells and supplies industrial-based hemp cannabidiol (CBD) products. Also today, the company was featured in a report by CannabisNewsWire which takes a look at how the authority in charge of overseeing cannabis in Oregon (the Oregon Liquor Control Commission) has released new rules that will make it easier for patients to access medical marijuana. Additionally, NetworkNewsWire released a report digging further into the subject, as SING has announced its plans to explore opportunities to produce industrial hemp through joint ventures with leading growers, as well as a potential investment in a development program for cannabidiol (“CBD”) extraction from hemp with passage of the 2108 Farm Bill. To view the full press release, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.012295, up 2.46%, on 7,657,756 volume with 189 trades. The average volume for the last 3 months is 4,571,328 and the stock's 52-week low/high is $0.012/$0.109.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software (OTC: PFSF) plans to initially employ its Agri-Blockchain B2B e-commerce platform to facilitate trade between Brazil and China. To view the full article, visit:

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The average volume for the last 3 months is 64 and the stock's 52-week low/high is $3.50/$5.50.

Recent News


Icon Exploration Inc. (TSX.V: IEX.H)

The QualityStocks Daily Newsletter would like to spotlight Icon Exploration Inc. (IEX.H).

To update the early warning report issued in August 2017 filed by Icon Exploration (TSX.V: IEX.H) director and CEO Rob Fia, the company recently announced the issuance of 312,500 common shares of the company to Fia at a price of $0.15 each pursuant to the exercise of share purchase warrants. To view the full press release, visit:

Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.


Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day. The stock's 52-week low/high is $0.25/$0.84.

Recent News


Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) was featured in a report by CannabisNewsWire which takes a look at how the authority in charge of overseeing cannabis in Oregon (the Oregon Liquor Control Commission) has released new rules that will make it easier for patients to access medical marijuana.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.279, even for the day. The average volume for the last 3 months is 375 and the stock's 52-week low/high is $0.244/$0.505.

Recent News


Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands (OTC: ZNGY) offers its residential and commercial customers access to a suite of conservation-based products and services through its Zero Cost Program. A recent article discussing the company reads, “Zenergy has the ideal platform to promote its Zero Cost Program. In April 2018, the company completed its acquisition of Enertrade Electric LLC, a Texas-based retail electric provider (“REP”) ( To view the full article, visit:

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0002, even for the day, on 18,163,600 volume with 13 trades. The average volume for the last 3 months is 53,746,983 and the stock's 52-week low/high is $0.000009/$0.013.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE), a global financial technology and value-added solutions provider that supports electronic payments in an omni-channel environment, is meeting the needs of businesses and consumers alike as the world’s retail environment continues to move more completely online. From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like PayOnline and United Payments, Net Element is transforming the online and mobile experience for the better (

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.10, off by 1.77%, on 117,349 volume with 591 trades. The average volume for the last 3 months is 318,306 and the stock's 52-week low/high is $3.75/$15.50.

Recent News


Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

When Yale University reported recently that anxiety over the future of the planet’s climate system is rising significantly in the United States (, the Ivy League institution created a metric for the psychological consequences of sustained changes in regional weather patterns and the media reports about them. While climate change is driving a growing sense of “climate grief” ( characterized by “a number of different emotions, including fear, anger, feelings of powerlessness, or exhaustion,” for many the global trend is spurring a call to action, as exemplified by the smart utilities management solutions offered by disruptive digital tech company Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8).

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.66, off by 1.49%, on 12,350 volume with 10 trades. The average volume for the last 3 months is 20,556 and the stock's 52-week low/high is $0.46/$1.58.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) recently reported that during its ongoing exploration and development of the Irgon Project, geotechnical field crews identified additional significant spodumene mineralization. Spodumene mineralization is recognized as being the primary source of hard-rock lithium. To view the full article, visit:

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.1366, off by 2.43%, on 95,842 volume with 47 trades. The average volume for the last 3 months is 72,327 and the stock's 52-week low/high is $0.128/$0.92.

Recent News


Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.


Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.31945, up 9.03%, on 133,488 volume with 72 trades. The average volume for the last 3 months is 208,094 and the stock's 52-week low/high is $0.189/$1.875.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.